5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: A multimechanism therapeutic approach? [4] (multiple letters)

Blood

Volumn 101, Issue 11, 2003, Pages 4644-4646

  Sigalotti, Luca ^c   Altomonte, Maresa ^c   Colizzi, Francesca ^c   Degan, Massimo ^c   Rupolo, Maurizio ^c   Zagonel, Vittorina ^c   Pinto, Antonio ^c   Gattei, Valter ^c   Maio, Michele ^a   Lübbert, Michael ^b   Wijermans, Pierre W ^c   Jones, Peter A ^c   Hellström Lindberg, Eva ^c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTILEUKEMIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; TUMOR ANTIGEN; AZACITIDINE; DRUG DERIVATIVE; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; DOSE RESPONSE; GENE SILENCING; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; LETTER; LOW DRUG DOSE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT INDICATION; AGED; BLOOD DISEASE; DNA METHYLATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; NOTE;

AGED; AGED, 80 AND OVER; AZACITIDINE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 0038142344     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3458     Document Type: Letter

References (0)